Danaher Corporation (DHR) PB Ratio: 2.47
Is Danaher Corporation’s P/B ratio high or low?
Danaher Corporation's P/B ratio of 2.47 is 29% below its 5-year average of 3.48, near the low end of its 5-year range (2.17–5.07).
12.36% below its 12-month average of 2.82.
DHR PB Ratio Chart
DHR Average PB Ratio Chart
DHR Current vs Average PB Ratio Chart
DHR PB Ratio Metrics
PB RATIO
2.47
PB RATIO AVG TTM
2.82
PB RATIO AVG 3Y
3.16
PB RATIO AVG 5Y
3.48
PB RATIO AVG 10Y
3.10
PB RATIO AVG 15Y
2.60
PB RATIO AVG 20Y
2.41
CURRENT VS TTM AVG
-12.36%
CURRENT VS 3Y AVG
-21.85%
CURRENT VS 5Y AVG
-28.94%
CURRENT VS 10Y AVG
-20.42%
CURRENT VS 15Y AVG
-5.05%
CURRENT VS 20Y AVG
+2.65%
DHR Competitors' PB Ratio
| NAME | MARKET CAP | PB RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Danaher Corporation (DHR) | $126.39B | 2.47 | 2.82 | 3.16 | 3.48 |
| CVS Health Corporation (CVS) | $126.70B | 1.62 | 1.29 | 1.17 | 1.37 |
| Bristol-Myers Squibb Company (BMY) | $116.13B | 5.79 | 5.81 | 5.35 | 4.99 |
| Vertex Pharmaceuticals Incorporated (VRTX) | $110.59B | 5.82 | 6.41 | 6.72 | 6.44 |
| Intuitive Surgical, Inc. (ISRG) | $144.79B | 8.48 | 10.30 | 10.61 | 9.88 |
| Pfizer Inc. (PFE) | $149.61B | 1.67 | 1.63 | 1.71 | 2.35 |
| Medtronic plc (MDT) | $102.72B | 2.11 | 2.44 | 2.28 | 2.41 |
| Abbott Laboratories (ABT) | $155.75B | 3.00 | 4.07 | 4.66 | 5.09 |
| Gilead Sciences, Inc. (GILD) | $156.35B | 6.48 | 7.47 | 6.02 | 5.35 |
| Elevance Health Inc. (ELV) | $86.47B | 2.03 | 1.73 | 2.37 | 2.67 |
P/B vs. its own history
At 2.47, P/B is in its normal range, sitting higher than 60% of its 20-year history.
20-year low
1.10
median
2.28
20-year high
5.07
Book Value Analysis
P/B Ratio
2.47
Market Price / Book Value per Share
Danaher Corporation PB Ratio Formula & Definition
PB Ratio = Market Cap / Total Shareholders' Equity
The price-to-book ratio compares market capitalization to book value (shareholders' equity). Lower values can indicate a cheaper valuation relative to net assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Danaher Corporation PB Ratio FAQ
- What is the P/B ratio for Danaher Corporation (DHR)?
- The P/B ratio for DHR stock is 2.47.
- Is Danaher Corporation's P/B ratio high or low?
- Danaher Corporation's P/B ratio of 2.47 is 29% below its 5-year average of 3.48, near the low end of its 5-year range (2.17–5.07).
- What is the TTM average P/B ratio for Danaher Corporation (DHR)?
- The TTM average P/B ratio for DHR stock is 2.82.
- What is the 3Y average P/B ratio for Danaher Corporation (DHR)?
- The 3Y average P/B ratio for DHR stock is 3.16.
- What is the 5Y average P/B ratio for Danaher Corporation (DHR)?
- The 5Y average P/B ratio for DHR stock is 3.48.
- What is the 10Y average P/B ratio for Danaher Corporation (DHR)?
- The 10Y average P/B ratio for DHR stock is 3.10.
- What is the 15Y average P/B ratio for Danaher Corporation (DHR)?
- The 15Y average P/B ratio for DHR stock is 2.60.
- What is the 20Y average P/B ratio for Danaher Corporation (DHR)?
- The 20Y average P/B ratio for DHR stock is 2.41.
Danaher Corporation PB Ratio History
| DATE | PB RATIO |
|---|---|
| 2026-06-10 | 2.47 |
| 2026-06-09 | 2.53 |
| 2026-06-08 | 2.47 |
| 2026-06-05 | 2.48 |
| 2026-06-04 | 2.51 |
| 2026-06-03 | 2.39 |
| 2026-06-02 | 2.37 |
| 2026-06-01 | 2.42 |
| 2026-05-29 | 2.45 |
| 2026-05-28 | 2.43 |
| 2026-05-27 | 2.33 |
| 2026-05-26 | 2.32 |
| 2026-05-22 | 2.31 |
| 2026-05-21 | 2.33 |
| 2026-05-20 | 2.30 |
| 2026-05-19 | 2.24 |
| 2026-05-18 | 2.20 |
| 2026-05-15 | 2.17 |
| 2026-05-14 | 2.21 |
| 2026-05-13 | 2.23 |
| 2026-05-12 | 2.23 |
| 2026-05-11 | 2.24 |
| 2026-05-08 | 2.30 |
| 2026-05-07 | 2.36 |
| 2026-05-06 | 2.35 |
| 2026-05-05 | 2.35 |
| 2026-05-04 | 2.34 |
| 2026-05-01 | 2.35 |
| 2026-04-30 | 2.40 |
| 2026-04-29 | 2.40 |
| 2026-04-28 | 2.40 |
| 2026-04-27 | 2.43 |
| 2026-04-24 | 2.38 |
| 2026-04-23 | 2.40 |
| 2026-04-22 | 2.47 |
| 2026-04-21 | 2.61 |
| 2026-04-20 | 2.63 |
| 2026-04-17 | 2.64 |
| 2026-04-16 | 2.62 |
| 2026-04-15 | 2.68 |
| 2026-04-14 | 2.69 |
| 2026-04-13 | 2.65 |
| 2026-04-10 | 2.57 |
| 2026-04-09 | 2.61 |
| 2026-04-08 | 2.66 |
| 2026-04-07 | 2.59 |
| 2026-04-06 | 2.60 |
| 2026-04-02 | 2.59 |
| 2026-04-01 | 2.58 |
| 2026-03-31 | 2.57 |
| 2026-03-30 | 2.49 |
| 2026-03-27 | 2.46 |
| 2026-03-26 | 2.55 |
| 2026-03-25 | 2.53 |
| 2026-03-24 | 2.57 |
| 2026-03-23 | 2.57 |
| 2026-03-20 | 2.56 |
| 2026-03-19 | 2.57 |
| 2026-03-18 | 2.59 |
| 2026-03-17 | 2.64 |
| 2026-03-16 | 2.59 |
| 2026-03-13 | 2.54 |
| 2026-03-12 | 2.52 |
| 2026-03-11 | 2.64 |
| 2026-03-10 | 2.64 |
| 2026-03-09 | 2.69 |
| 2026-03-06 | 2.65 |
| 2026-03-05 | 2.73 |
| 2026-03-04 | 2.77 |
| 2026-03-03 | 2.76 |
| 2026-03-02 | 2.79 |
| 2026-02-27 | 2.85 |
| 2026-02-26 | 2.83 |
| 2026-02-25 | 2.84 |
| 2026-02-24 | 2.83 |
| 2026-02-23 | 2.95 |
| 2026-02-20 | 2.93 |
| 2026-02-19 | 2.95 |
| 2026-02-18 | 2.91 |
| 2026-02-17 | 2.88 |
| 2026-02-13 | 2.97 |
| 2026-02-12 | 3.00 |
| 2026-02-11 | 3.07 |
| 2026-02-10 | 3.07 |
| 2026-02-09 | 3.03 |
| 2026-02-06 | 3.03 |
| 2026-02-05 | 3.02 |
| 2026-02-04 | 3.07 |
| 2026-02-03 | 3.03 |
| 2026-02-02 | 3.12 |
| 2026-01-30 | 3.06 |
| 2026-01-29 | 3.07 |
| 2026-01-28 | 3.14 |
| 2026-01-27 | 3.29 |
| 2026-01-26 | 3.31 |
| 2026-01-23 | 3.28 |
| 2026-01-22 | 3.36 |
| 2026-01-21 | 3.38 |
| 2026-01-20 | 3.27 |
| 2026-01-16 | 3.30 |
| 2026-01-15 | 3.35 |
| 2026-01-14 | 3.33 |
| 2026-01-13 | 3.29 |
| 2026-01-12 | 3.34 |
| 2026-01-09 | 3.33 |
| 2026-01-08 | 3.28 |
| 2026-01-07 | 3.29 |
| 2026-01-06 | 3.31 |
| 2026-01-05 | 3.29 |
| 2026-01-02 | 3.22 |
| 2025-12-31 | 3.20 |
| 2025-12-30 | 3.22 |
| 2025-12-29 | 3.22 |
| 2025-12-26 | 3.22 |
| 2025-12-24 | 3.23 |
| 2025-12-23 | 3.23 |
| 2025-12-22 | 3.19 |
| 2025-12-19 | 3.14 |
| 2025-12-18 | 3.14 |
| 2025-12-17 | 3.11 |
| 2025-12-16 | 3.14 |
| 2025-12-15 | 3.19 |
| 2025-12-12 | 3.16 |
| 2025-12-11 | 3.25 |
| 2025-12-10 | 3.22 |
| 2025-12-09 | 3.12 |
| 2025-12-08 | 3.14 |
| 2025-12-05 | 3.16 |
| 2025-12-04 | 3.17 |
| 2025-12-03 | 3.19 |
| 2025-12-02 | 3.17 |
| 2025-12-01 | 3.13 |
| 2025-11-28 | 3.17 |
| 2025-11-26 | 3.19 |
| 2025-11-25 | 3.22 |
| 2025-11-24 | 3.17 |
| 2025-11-21 | 3.18 |
| 2025-11-20 | 3.10 |
| 2025-11-19 | 3.11 |
| 2025-11-18 | 3.15 |
| 2025-11-17 | 3.08 |
| 2025-11-14 | 3.09 |
| 2025-11-13 | 3.09 |
| 2025-11-12 | 3.07 |
| 2025-11-11 | 3.02 |
| 2025-11-10 | 2.95 |
| 2025-11-07 | 2.93 |
| 2025-11-06 | 2.94 |
| 2025-11-05 | 2.97 |
| 2025-11-04 | 2.99 |
| 2025-11-03 | 2.99 |
| 2025-10-31 | 3.01 |
| 2025-10-30 | 3.01 |
| 2025-10-29 | 2.99 |
| 2025-10-28 | 3.03 |
| 2025-10-27 | 3.09 |
| 2025-10-24 | 3.12 |
| 2025-10-23 | 3.11 |
| 2025-10-22 | 3.05 |
| 2025-10-21 | 3.09 |
| 2025-10-20 | 2.91 |
| 2025-10-17 | 2.87 |
| 2025-10-16 | 2.90 |
| 2025-10-15 | 2.83 |
| 2025-10-14 | 2.83 |
| 2025-10-13 | 2.82 |
| 2025-10-10 | 2.78 |
| 2025-10-09 | 2.81 |
| 2025-10-08 | 2.82 |
| 2025-10-07 | 2.87 |
| 2025-10-06 | 2.91 |
| 2025-10-03 | 2.95 |
| 2025-10-02 | 2.89 |
| 2025-10-01 | 2.93 |
| 2025-09-30 | 2.72 |
| 2025-09-29 | 2.56 |
| 2025-09-26 | 2.54 |
| 2025-09-25 | 2.49 |
| 2025-09-24 | 2.55 |
| 2025-09-23 | 2.61 |
| 2025-09-22 | 2.62 |
| 2025-09-19 | 2.66 |
| 2025-09-18 | 2.68 |
| 2025-09-17 | 2.65 |
| 2025-09-16 | 2.62 |
| 2025-09-15 | 2.59 |
| 2025-09-12 | 2.61 |
| 2025-09-11 | 2.68 |
| 2025-09-10 | 2.65 |
| 2025-09-09 | 2.67 |
| 2025-09-08 | 2.73 |
| 2025-09-05 | 2.75 |
| 2025-09-04 | 2.73 |
| 2025-09-03 | 2.74 |
| 2025-09-02 | 2.80 |
| 2025-08-29 | 2.83 |
| 2025-08-28 | 2.82 |
| 2025-08-27 | 2.82 |
| 2025-08-26 | 2.83 |
| 2025-08-25 | 2.85 |
| 2025-08-22 | 2.91 |
| 2025-08-21 | 2.80 |
| 2025-08-20 | 2.90 |
| 2025-08-19 | 2.92 |
| 2025-08-18 | 2.87 |
| 2025-08-15 | 2.90 |
| 2025-08-14 | 2.89 |
| 2025-08-13 | 2.87 |
| 2025-08-12 | 2.83 |
| 2025-08-11 | 2.74 |
| 2025-08-08 | 2.76 |
| 2025-08-07 | 2.73 |
| 2025-08-06 | 2.68 |
| 2025-08-05 | 2.73 |
| 2025-08-04 | 2.71 |
| 2025-08-01 | 2.71 |
| 2025-07-31 | 2.71 |
| 2025-07-30 | 2.80 |
| 2025-07-29 | 2.84 |
| 2025-07-28 | 2.79 |
| 2025-07-25 | 2.82 |
| 2025-07-24 | 2.79 |
| 2025-07-23 | 2.72 |
| 2025-07-22 | 2.61 |
| 2025-07-21 | 2.58 |
| 2025-07-18 | 2.69 |
| 2025-07-17 | 2.76 |
| 2025-07-16 | 2.74 |
| 2025-07-15 | 2.73 |
| 2025-07-14 | 2.80 |
| 2025-07-11 | 2.90 |
| 2025-07-10 | 2.91 |
| 2025-07-09 | 2.85 |
| 2025-07-08 | 2.84 |
| 2025-07-07 | 2.83 |
| 2025-07-03 | 2.88 |
| 2025-07-02 | 2.87 |
| 2025-07-01 | 2.85 |
| 2025-06-30 | 2.80 |
| 2025-06-27 | 2.82 |
| 2025-06-26 | 2.86 |
| 2025-06-25 | 2.85 |
| 2025-06-24 | 2.80 |
| 2025-06-23 | 2.78 |
| 2025-06-20 | 2.78 |
| 2025-06-18 | 2.76 |
| 2025-06-17 | 2.77 |
| 2025-06-16 | 2.85 |
| 2025-06-13 | 2.84 |
| 2025-06-12 | 2.91 |
| 2025-06-11 | 2.90 |
| 2025-06-10 | 2.87 |
| 2025-06-09 | 2.82 |
| 2025-06-06 | 2.78 |
| 2025-06-05 | 2.72 |
| 2025-06-04 | 2.74 |
| 2025-06-03 | 2.72 |
| 2025-06-02 | 2.68 |
| 2025-05-30 | 2.69 |
| 2025-05-29 | 2.70 |
Showing the most recent 260 of 5,031 data points. The chart above shows the full history.
Related Metrics
About Danaher Corporation
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Rainer Blair